RFP QuestBeta
ClosedStage · preprocurement

UK Health Security Agency

Centralised Flu Procurement

Medical Equipment & PharmaCPV 33000000 33600000 33650000 33651000
Value£1
Deadline29 Nov 2024
Published28 Oct 2024
RegionUK-wide
Timeline
Published 28 Oct 2024ClosedCloses 29 Nov 2024
Contract value in context
£1total contract value
median £123k
this tender£0£16.5m

This sits below the typical range for Medical Equipment & Pharmaceuticals contracts — a smaller, more accessible award. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

Following the publication of the NHS Vaccination Strategy (2023), NHSE, UKHSA and DHSC are exploring whether centralising the procurement and/or supply of adult flu vaccine could deliver a more efficient and effective outcome and provide improvements on the current models.

UKHSA, as the potential Contracting Authority, are leading the pre-market engagement activity with the purpose to: • Gain a better understanding of the 'as-is' adult NHS flu programme from the perspective of vaccine manufacturers and wholesalers • Understand what impact centralising the procurement and/or supply of adult flu vaccine would potentially have on the market including current capability and capacity; options under consideration include o Procuring Adult Flu Vaccines using a Centralised Framework Contract o UKHSA Procuring Adult Flu Vaccines and maintaining existing supply and distribution methods o UKHSA Procuring Adult Flu Vaccines and ingesting supply centrally for distribution o Maintaining the status quo • Explore any potential barriers, opportunities, benefits or risks there may be with a central procurement and/or supply approach. • Have an open dialogue with the market to ensure a full understanding of the future landscape.

The market engagement will take the form of a questionnaire available via our e-procurement system, which you will be asked to complete and return.

Once returned, you may be invited for a 1:1 meeting with the project team to discuss your answers and provide clarification.

It is anticipated that these meetings will take place during November/December 2024.

Who would we like to hear from?

We are keen to engage with those suppliers who already have a licenced adult flu vaccine and/or have experience of the UK adult flu market, who have an adult flu vaccine in development, or who may have an adult flu vaccine in their future product development pipeline, and with medical logistics providers both wholesale and distribution.

How to participate?

The opportunity will be available on the Atamis eTendering system, access here: https://atamis-1928.my.site.com/s/Welcome .

If you do not already have an account you can easily register for one via the same link.

You will then be able to search for this opportunity and access the questionnaire and any other related documents.

Please note that all correspondence must be conducted through the Atamis system.

The response window will close at 5pm on Friday 29th November 2024.

Key requirements

What the supplier must deliver

01

Following the publication of the NHS Vaccination

Following the publication of the NHS Vaccination Strategy (2023), NHSE, UKHSA and DHSC are exploring whether centralising the procurement and/or supply of adult flu vaccine could deliver a more efficient and effective outcome and provide improvements on the current models.

02

Understand what impact centralising the procurement and/or

Understand what impact centralising the procurement and/or supply of adult flu vaccine would potentially have on the market including current capability and capacity; options under consideration include.

03

O UKHSA Procuring Adult Flu Vaccines

o UKHSA Procuring Adult Flu Vaccines and maintaining existing supply and distribution methods.

04

O UKHSA Procuring Adult Flu Vaccines

o UKHSA Procuring Adult Flu Vaccines and ingesting supply centrally for distribution.

05

Explore any potential barriers, opportunities, benefits or

Explore any potential barriers, opportunities, benefits or risks there may be with a central procurement and/or supply approach.

Derived from the notice text — always confirm against the original documents.

Buyer intelligence

Make the case to bid

Reveal who to approach at UK Health Security Agency, and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
fbf39c78-4d74-4b78-8a4e-b0df32633e9d
Stage
preprocurement · Closed
Source
Contracts Finder
Buyer ref
CF-2623800D0O000000rwimUAA
View the original notice on Contracts Finder

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Medical Equipment & Pharmaceuticals

Assembling the market network…

UK Health Security Agency’s tender network

Assembling the network…

Also open now

Similar open tenders

Staff Flu Vaccination Programme

Hull City Council

Closes 20 Jul 2026Healthcare
£25kValue

Procurement of 1 No Navigational Robot-assisted Bronchoscopy platform

Norfolk and Norwich University Hospitals NHS Foundation Trust

Closes 31 Jul 2026Medical Equipment & Pharma
£700kValue